| Turcja | Austria | Hiszpania | |
| Przeszczep wątroby | od $45,000 | od $320,000 | od $120,000 |
| Leczenie marskości wątroby komórkami macierzystymi | od $12,000 | od $40,000 | od $20,000 |
Turkey is a key destination for cirrhosis treatment, with hospitals like Hisar Hospital Intercontinental, Medipol Mega University Hospital, and Memorial Şişli Hospital accredited by the Joint Commission International (JCI). Hisar Hospital Intercontinental attracts over 500,000 patients annually, while Medipol Mega University Hospital uses advanced technology like the Da Vinci Surgical System. Memorial Şişli Hospital has a 90% success rate in organ transplants.
Innovative cirrhosis treatments in Turkey include liver transplantation, TIPS, radiofrequency ablation, and endoscopic variceal ligation. The 5-year survival rate after a liver transplant in Turkey reaches up to 78%, aligning with international rates due to precise diagnostics and personalized treatment plans.
Germany excels in cirrhosis treatment, with leading hospitals like Asklepios Hospital Barmbek, Nordrhein-Westfalen Clinic Complex, and Nordwest Clinic (Krankenhaus) offering advanced care.
Accredited by the Cooperation for Transparency and Quality in Health Service, these centers provide liver transplantation, radiofrequency ablation, TIPS, and stem cell therapy. Germany's cirrhosis treatment leads to a 78% 5-year survival rate on average.
Spain is a leader in cirrhosis treatment, with top institutions accredited by the Joint Commission International. Clinics like Centro Médico Teknon, Hospital Universitario HM Sanchinarro, and Hospital HM Nou Delfos offer advanced treatments, including liver transplantation, TIPS, radiofrequency ablation, and percutaneous ethanol injection.
The 5-year survival rate for liver transplantation in Spain reaches 79.5%, showcasing the high standard of care. Spanish hospitals utilize the latest technology and skilled professionals to provide personalized treatment plans.
Israel excels in cirrhosis treatment, with Sourasky Medical Center (Ichilov) and Hadassah Medical Center at the forefront. Sourasky boasts a 90% success rate in oncology and is accredited by the Joint Commission International. Hadassah Medical Center, serving over 1,000,000 patients annually, specializes in neurosurgery, orthopedics, and oncology. It is listed in Newsweek's World's Best Hospitals.
Israel's cirrhosis survival rates are enhanced by liver transplantation, hepatic artery embolization, and tauroursodeoxycholic acid therapy. Liver transplantation has a 90% survival rate in the first year. Advanced procedures like radiofrequency ablation, TIPS, and stem cell therapy further solidify Israel's position in medical innovation.